Quantcast

Latest Vaccines Stories

2014-03-27 12:30:08

ATLANTA, March 27, 2014 /PRNewswire-USNewswire/ -- Getting a flu vaccine reduces a child's risk of flu-related intensive care hospitalization by 74 percent, according to a CDC study published today in the Journal of Infectious Diseases. The study is the first to estimate vaccine effectiveness (VE) against flu admissions to pediatric intensive care units (PICU). It illustrates the important protection flu vaccine can provide to children against more serious flu outcomes. CDC...

2014-03-26 12:28:56

ANN ARBOR, Mich., March 26, 2014 /PRNewswire/ -- NanoBio Corporation today announced a licensing agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for the use of its nanoemulsion (NE) adjuvant technology. Under the agreement, Merck receives exclusive rights to NanoBio's NE adjuvant for use in an intranasal respiratory syncytial virus (RSV) vaccine and non-exclusive rights for use in an intranasal seasonal influenza and/or...

2014-03-26 08:28:41

PRINCETON, N.J., March 26, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today its financial results for the year ended December 31, 2013. Soligenix's revenues for the year ended were $3.2 million as compared to $3.1 million for...

2014-03-26 04:20:59

Biotech Judged First-in-Class for Cervical Pre-Cancer Immunotherapy (VGX-3100), Which Reports Phase II Results Mid-year 2014 BLUE BELL, Pa., March 26, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that it was recognized with three industry awards at the World Vaccine Congress, which is being held this week in Washington, D.C. The Vaccine Industry Excellence (ViE) Awards recognize outstanding vaccine advancements and achievements of therapeutic...

2014-03-25 08:30:28

ROCKVILLE, Md., March 25, 2014 /PRNewswire/ -- VLP Therapeutics, Inc. ("VLP"), a Rockville-based biotechnology company focusing on the research and development of next generation antibody agents and therapeutic as well as preventive vaccines based upon a novel and proprietary i- VLP technology (which stands for "inserted alpha virus like particle"), today announced that Ryuji Ueno, M.D., Ph.D., Ph.D., Co-Founder and former Chair, Chief Executive Officer and Chief Scientific Officer of...

2014-03-25 08:23:39

DUBLIN, Mar. 25, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n86mjg/china_human ) has announced the addition of the "Concise Analysis of the International Human Vaccine Industry" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) In the wake of China's economic growth and enhanced disease prevention awareness, Chinese human vaccine market has been expanding. In 2012, Chinese human vaccine market valued RMB10.5...

2014-03-20 16:26:59

DUBLIN, March 20, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/n8dfqv/china_influenza) has announced the addition of the "China Influenza Vaccine Industry Report 2014" [http://www.researchandmarkets.com/research/n8dfqv/china_influenza ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The China Influenza Vaccine Industry Report 2014 is a professional and in-depth study on the...

2014-03-19 20:21:13

- Conference call scheduled for Thursday, March 20, 2014 at 8:00 AM EDT - BEIJING, March 19, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited fourth quarter and full year financial results for the period ended December 31, 2013. Unaudited Fourth Quarter 2013 Financial Highlights (period-over-period comparisons to fourth quarter 2012) -- Quarterly sales increased by 17.1% to $22.9 million...

H1N1 Death Risk Dramatically Lowered If Antivirals Are Administered Within Two Days Of Symptoms
2014-03-19 09:19:25

Lawrence LeBlond for redOrbit.com - Your Universe Online Tamiflu treatments have been somewhat controversial over the past few years, with some evidence showing the H7N9 bird flu gaining resistance to the drug and others questioning the effectiveness of the antiviral medication. However, according to a large meta-analytical study, it has been found that adults hospitalized with H1N1 during the 2009-2010 influenza pandemic were 25 percent less likely to die from the disease if they were...

2014-03-18 12:32:29

LONDON, March 18, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis World Adult Vaccines Market - Market OverviewFor much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles,...


Latest Vaccines Reference Libraries

72_d0e074525de5bb741daf382f8d62213f
2011-04-25 16:38:12

Neisseria meningitidis is a heterotrophic gram-negative diplococcal bacterium best known for its role in meningitis and other forms of meningococcal disease such as meningococcemia. It is a major cause of morbidity and mortality during childhood in industrialized countries and is responsible for epidemics in Africa and in Asia. In the US there are approximately 2500 to 3500 cases of N. meningitides infections. Children under 5 are at a higher risk as well as people in the sub-Saharan...

45_cbb742ff010fcfbfac5b5b73fd2e0254
2011-02-23 17:23:51

Poliovirus, the causative agent of poliomyelitis and a member of the family of Picornaviridae, is a human enterovirus. It is composed of an RNA genome that is a single-stranded positive-sense RNA. It was first isolate in 1909 and was published in 1981. It is one of the most well characterized viruses and has become a useful model system for understanding the biology of RNA viruses. It infects human cells by binding to an immunoglobulin-like receptor on the cell surface. The three...

More Articles (2 articles) »
Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related